2006Chinese Archives of Otolaryngology-head and Neck SurgeryRequires access

Expression of interleukin -12 and correlation between interleukin -12 and eosinophils in nasal mucosa in allergic rhinitis mice

deng qiu, Zhou Yun, yang jun, Erzhong Fan

Open publisher page 0 citations

Abstract

OBJECTIVE To observe the expres-sion of interleukin-12 and eosinophils in the nasal mu-cosa of allergic rhinitis mice. METHODS Thirty nine male BALB/c mice,6~8 weeks old,were randomly divided into three groups: control group,allergic rhinitis (AR)group, and Budesonide treatment group. Al-lergic rhinitis model in mice were established by using ovalbumin intraperitoneal immunization and nasal anti-gen challenge. The nasal mucosa obtained from mice of three groups were stained routinely by HE and im-munohistochemical method to observe the distribu-tion and expression of interleukin-12 and eosinophils. RESULTS The expression of eosinophils in the nasal mucosa of AR group was significantly higher than con-trol group(P0.01). After treatment with Budes-onide,eosinophils’expression were decreased in nasal mucosa(P0.01,compared with the AR group). However,interleukin-12 expression was significantly increased compared with AR group(P 0.01),and had no significant difference compared with the control group. There was a negative relation-ship between the expression of interleukin-12 and eosino-phil in nasal mucosa (R =0.9252). CONCLUSION The abnormal expression of interleukin-12 in the nasal mu-cosa played an important role in the pathogenic mecha-nism of AR. The recovery or increase expression of interleukin-12 in topical tissue in vivo could suppress the expression of eosinophils and may improve the therapeutic effectiveness of AR.

About this research paper

What this paper is about

OBJECTIVE To observe the expres-sion of interleukin-12 and eosinophils in the nasal mu-cosa of allergic rhinitis mice. METHODS Thirty nine male BALB/c mice,6~8 weeks old,were randomly divided into three groups: control group,allergic rhinitis (AR)group, and Budesonide treatment group. Al-lergic rhinitis model in mice were established by using ovalbumin intraperitoneal immunization and nasal anti-gen challenge. The nasal mucosa obtained from mice of three groups were stained routinely by HE and im-munohistochemical method to observe the distribu-tion and expression of interleukin-12 and eosinophils. RESULTS The expression of eosinophils in the nasal mucosa of AR group was significantly higher than con-trol group(P0.01). After treatment with Budes-onide,eosinophils’expression were decreased in nasal mucosa(P0.01,compared with the AR group). However,interleukin-12 expression was significantly increased compared with AR group(P 0.01),and had no significant difference compared with the control group. There was a negative relation-ship between the expression of interleukin-12 and eosino-phil in nasal mucosa (R =0.9252). CONCLUSION The abnormal expression of interleukin-12 in the nasal mu-cosa played an important role in the pathogenic mecha-nism of AR. The recovery or increase expression of interleukin-12 in topical tissue in vivo could suppress the expression of eosinophils and may improve the therapeutic effectiveness of AR.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE To observe the expres-sion of interleukin-12 and eosinophils in the nasal mu-cosa of allergic rhinitis mice. METHODS Thirty nine male BALB/c mice,6~8 weeks old,were randomly divided into three groups: control group,allergic rhinitis (AR)group, and Budesonide treatment group. Al-lergic rhinitis model in mice were established by using ovalbumin intraperitoneal immunization and nasal anti-gen challenge. The nasal mucosa obtained from mice of three groups were stained routinely by HE and im-munohistochemical method to observe the distribu-tion and expression of interleukin-12 and eosinophils. RESULTS The expression of eosinophils in the nasal mucosa of AR group was significantly higher than con-trol group(P0.01). After treatment with Budes-onide,eosinophils’expression were decreased in nasal mucosa(P0.01,compared with the AR group). However,interleukin-12 expression was significantly increased compared with AR group(P 0.01),and had no significant difference compared with the control group. There was a negative relation-ship between the expression of interleukin-12 and eosino-phil in nasal mucosa (R =0.9252). CONCLUSION The abnormal expression of interleukin-12 in the nasal mu-cosa played an important role in the pathogenic mecha-nism of AR. The recovery or increase expression of interleukin-12 in topical tissue in vivo could suppress the expression of eosinophils and may improve the therapeutic effectiveness of AR.

Key concepts: Mucous membrane of nose, Ovalbumin, Medicine, Interleukin 5, Budesonide, Interleukin, Nasal administration, Interleukin 4

Related papers

Back to paper searchBrowse research topicsOriginal source
Expression of interleukin -12 and correlation between interleukin -12 and eosinophils in nasal mucosa in allergic rhinitis mice — Research Paper | ScholarLens